| 書目名稱 | Handbook of Stroke Prevention in Clinical Practice |
| 編輯 | Karen L. Furie,Peter J. Kelly |
| 視頻video | http://file.papertrans.cn/423/422244/422244.mp4 |
| 概述 | Includes supplementary material: |
| 叢書名稱 | Current Clinical Neurology |
| 圖書封面 |  |
| 描述 | Despite major advances in the understanding of stroke mechanisms that have occurred over the past quarter century, stroke continues to rank among the leading causes of death and disability worldwide. Although currently it may be difficult to believe, early doubts were expressed as to whether inter- ventions in risk factors for either coronary disease or stroke would actually lead to a reduction in the incidence of these disorders. However, large clini- cal trials in hypertension, carotid disease, atrial fibrillation, and antithrombotic and antiplatelet therapies have effectively demonstrated the efficacy of these targeted interventions in reducing stroke incidence. More recently, after earlier uncertainty regarding the role of elevated lipids as a risk factor for stroke, clinical trials of the statins have also demonstrated a significant reduction in the incidence of ischemic stroke. However, as em- phasized in Handbook of Stroke Prevention in Clinical Practice, despite these gains and the initial decline in stroke incidence that did occur in the 1960s and 1970s, the incidence of stroke disappointingly has failed to show a fur- ther significant decline since that time. The editors |
| 出版日期 | Book 2004 |
| 關(guān)鍵詞 | Stent; atherosclerosis; blood pressure; embolism; hypertension; stroke |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-1-59259-769-7 |
| isbn_softcover | 978-1-4684-9856-1 |
| isbn_ebook | 978-1-59259-769-7Series ISSN 1559-0585 Series E-ISSN 2524-4043 |
| issn_series | 1559-0585 |
| copyright | Springer Science+Business Media New York 2004 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-11 18:06
發(fā)表于 2025-3-21 18:59:55
